- List
- By Topic
- On Map
- Search Details

"Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:

"Diabetic Nephropathies" (323 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02517320 | Completed | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
293 | All | 20 Years to 75 Years (Adult, Older Adult) | NCT02517320 | MT-3995-J05 | July 2015 | November 2016 | January 2017 | August 7, 2015 | March 3, 2017 |
|
|||
2 | NCT03824379 | Not yet recruiting New |
Magnesium Supplementation in Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
60 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT03824379 | PHCL932 | March 1, 2019 | November 1, 2019 | November 1, 2019 | January 31, 2019 | January 31, 2019 | ||||
3 | NCT02205372 | Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
31 | All | 20 Years to 75 Years (Adult, Older Adult) | NCT02205372 | MT-3995-J04 | July 2014 | August 2015 | August 2015 | July 31, 2014 | September 16, 2015 |
|
|||
4 | NCT02204280 | Completed | The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy |
|
Observational |
|
Other |
|
|
120 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02204280 | HebeiMUTH | August 2014 | July 2015 | July 2015 | July 30, 2014 | July 21, 2015 | ||||||
5 | NCT01889277 | Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
51 | All | 20 Years to 75 Years (Adult, Older Adult) | NCT01889277 | MT-3995-J03 | July 2013 | January 2015 | January 2015 | June 28, 2013 | January 27, 2015 |
|
|||
6 | NCT03436693 | Recruiting | Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
300 | All | 30 Years and older (Adult, Older Adult) | NCT03436693 | TA-7284-14 | February 15, 2018 | September 2021 | September 2021 | February 16, 2018 | April 5, 2018 |
|
|||
7 | NCT02704494 | Completed | Resveratrol's Effects in Diabetic Nephropathy |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
60 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02704494 | 93-01-49-9028 | ReDNeph | March 2016 | February 2017 | February 2017 | March 10, 2016 | October 5, 2017 |
|
||
8 | NCT03407989 | Recruiting | SWIDINEP a Swiss Diabetic Nephropathy Cohort |
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03407989 | CER 43/12 | SWIDINEP | January 1, 2014 | January 1, 2022 | January 1, 2022 | January 23, 2018 | January 24, 2018 |
|
||||
9 | NCT03147677 | Recruiting | Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
216 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03147677 | 320.6750.16025 | July 2016 | July 2018 | December 2018 | May 10, 2017 | October 25, 2017 |
|
|||
10 | NCT01756703 | Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
67 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01756703 | MT-3995-E06 | November 2012 | August 2014 | August 2014 | December 27, 2012 | February 9, 2015 |
|
|||
11 | NCT01756716 | Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
49 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01756716 | MT-3995-E07 | December 2012 | September 2014 | September 2014 | December 27, 2012 | February 9, 2015 |
|
|||
12 | NCT03658317 | Not yet recruiting | Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
150 | All | Child, Adult, Older Adult | NCT03658317 | RI in diabetic nephropathy | September 2018 | March 2019 | September 2019 | September 5, 2018 | September 14, 2018 | ||||
13 | NCT03804879 | Recruiting | Safety, Tolerability and Efficacy of LMB763 in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
100 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03804879 | CLMB763X2202 | February 5, 2019 | May 28, 2021 | May 28, 2021 | January 15, 2019 | February 15, 2019 |
|
|||
14 | NCT03288571 | Not yet recruiting | Use of Wharton Jelly in Diabetic Nephropathy |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
20 | All | 35 Years to 70 Years (Adult, Older Adult) | NCT03288571 | DNJUCTC | November 2019 | December 2019 | January 2020 | September 20, 2017 | June 6, 2018 | ||||
15 | NCT02442921 | Recruiting | Colchicine for Diabetic Nephropathy Trial |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / Industry |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT02442921 | SHEBA-2015-1560-SK-CTIL | CDNT | February 22, 2016 | April 30, 2019 | April 30, 2019 | May 13, 2015 | May 9, 2017 |
|
||
16 | NCT03174821 | Completed | Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
160 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03174821 | IPT-OX-10 | October 20, 2010 | May 16, 2014 | May 16, 2014 | June 5, 2017 | June 5, 2017 | ||||
17 | NCT00317954 | Completed | Spironolactone in Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT00317954 | 2612-2233 | September 2003 | July 2005 | April 25, 2006 | April 25, 2006 |
|
||||
18 | NCT00708981 | Completed | Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
120 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00708981 | Metabolism IST IRB# 06-177 |
May 2007 | October 2013 | December 2013 | July 3, 2008 | October 2, 2014 |
|
|||
19 | NCT02690883 | Unknown † | Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
90 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02690883 | ESR-14-10425 | March 2016 | March 2017 | October 2017 | February 24, 2016 | February 24, 2016 | ||||
20 | NCT02768948 | Recruiting | Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT02768948 | 16-AOI-09 | May 5, 2017 | July 2019 | July 2019 | May 11, 2016 | November 21, 2018 |
|
|||
21 | NCT00782847 | Completed | Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
125 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00782847 | DiaNe-Studie | DiaNe | July 2004 | January 2007 | January 2007 | October 31, 2008 | October 31, 2008 |
|
||
22 | NCT01005121 | Unknown † | Colchicine for Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
12 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT01005121 | SHEBA-09-7369-AL-CTIL | December 2009 | December 2014 | December 2015 | October 30, 2009 | January 4, 2013 |
|
|||
23 | NCT01779089 | Unknown † | Minocycline and Proteinuria in Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT01779089 | 013400 | February 2009 | March 2016 | March 2016 | January 30, 2013 | May 21, 2015 |
|
|||
24 | NCT01003236 | Completed | Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
60 | All | 30 Years to 70 Years (Adult, Older Adult) | NCT01003236 | 4774 | October 2010 | October 2011 | November 2011 | October 28, 2009 | June 25, 2012 |
|
|||
25 | NCT02488252 | Recruiting | Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
148 | All | 35 Years to 80 Years (Adult, Older Adult) | NCT02488252 | DN-CM-1 | SCHEMATIC | July 2015 | June 2019 | December 2019 | July 2, 2015 | May 17, 2018 |
|
||
26 | NCT01858532 | Terminated | Study Of Diabetic Nephropathy With Atrasentan |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
5112 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT01858532 | M11-352 2012-005848-21 |
SONAR | May 17, 2013 | March 29, 2018 | March 29, 2018 | May 21, 2013 | April 26, 2018 |
|
||
27 | NCT02410499 | Withdrawn | Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
0 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT02410499 | MLN1202-2005 2014-005142-21 U1111-1168-1426 |
May 20, 2015 | November 17, 2015 | November 17, 2015 | April 7, 2015 | September 25, 2017 | ||||
28 | NCT00967629 | Completed | Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT00967629 | GCO 08-0976 | June 2009 | February 2010 | February 2010 | August 28, 2009 | November 18, 2011 |
|
|||
29 | NCT00130312 | Terminated | Effect of Sulodexide in Overt Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Industry / Other |
|
|
1248 | All | 18 Years and older (Adult, Older Adult) | NCT00130312 | KRX-101-401 | August 2005 | March 2008 | March 2008 | August 15, 2005 | May 5, 2015 |
|
|||
30 | NCT01774981 | Completed Has Results |
Study of LY3016859 in Participants With Diabetic Nephropathy |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
60 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01774981 | 14353 I5V-MC-TGAB 2012-004496-40 |
March 2013 | August 2015 | August 2015 | January 24, 2013 | October 6, 2017 | August 15, 2017 |
|
||
31 | NCT01796418 | Unknown † | Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
102 | All | 20 Years to 75 Years (Adult, Older Adult) | NCT01796418 | BESTinDN-001 | March 2013 | August 2014 | February 21, 2013 | December 16, 2013 |
|
||||
32 | NCT01935167 | Completed | To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
158 | All | 30 Years and older (Adult, Older Adult) | NCT01935167 | DW1029M | October 2013 | August 2014 | February 2015 | September 4, 2013 | February 17, 2017 |
|
|||
33 | NCT01068041 | Completed | Effects of PH3 in Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
100 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01068041 | PH-CP016 | PH3 | August 2010 | July 2014 | September 2015 | February 12, 2010 | November 4, 2015 |
|
||
34 | NCT00870402 | Unknown † | Aldosterone in Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
160 | All | 30 Years to 70 Years (Adult, Older Adult) | NCT00870402 | SA08I20032 | ALDODN | March 2009 | December 2009 | March 2010 | March 27, 2009 | March 27, 2009 |
|
||
35 | NCT01768611 | Completed | SLC2A1 Variants and Diabetic Nephropathy |
|
Observational |
|
Other |
|
|
449 | All | 11 Years and older (Child, Adult, Older Adult) | NCT01768611 | FMUSP-LIM25-001 | October 2004 | October 2012 | October 2012 | January 15, 2013 | January 16, 2013 |
|
|||||
36 | NCT01273675 | Unknown † | An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy |
|
Observational |
|
Other |
|
100 | All | 30 Years to 75 Years (Adult, Older Adult) | NCT01273675 | 201008056R | September 2010 | January 10, 2011 | January 10, 2011 | |||||||||
37 | NCT00320060 | Completed | Effect of Pyridorin in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
128 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00320060 | PYR-206 | October 2001 | January 2003 | April 27, 2006 | April 27, 2006 | ||||||
38 | NCT00320021 | Completed | Effect of Pyridorin in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
80 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00320021 | PYR-205/207 PYR-205 PYR-207 |
July 2002 | September 2003 | April 27, 2006 | April 27, 2006 | |||||
39 | NCT00565318 | Completed | Benfotiamine in Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
86 | All | 40 Years to 75 Years (Adult, Older Adult) | NCT00565318 | BENFO-1 NL17390.075.07 |
Benfo | December 2007 | June 2009 | June 2009 | November 29, 2007 | November 16, 2009 |
|
||
40 | NCT01601236 | Completed Has Results |
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
34 | All | 18 Years and older (Adult, Older Adult) | NCT01601236 | QSC01-DN-01 | May 2012 | January 2016 | March 2016 | May 17, 2012 | August 21, 2017 | July 24, 2017 |
|
||
41 | NCT01163591 | Completed | To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy |
|
Observational |
|
Other |
|
|
100 | All | 21 Years to 75 Years (Adult, Older Adult) | NCT01163591 | CRE-2008.470-T | January 2009 | October 2009 | October 2009 | July 16, 2010 | October 12, 2015 |
|
|||||
42 | NCT01109212 | Completed | The Effects of Bindarit in Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
100 | All | 30 Years to 70 Years (Adult, Older Adult) | NCT01109212 | 004SC06084 2006-006191-38 |
March 2007 | November 2008 | December 2008 | April 23, 2010 | March 30, 2016 |
|
|||
43 | NCT01252056 | Completed | A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
353 | All | 40 Years to 75 Years (Adult, Older Adult) | NCT01252056 | 260-09-805-01 | March 2010 | December 2012 | December 2012 | December 2, 2010 | May 8, 2013 |
|
|||
44 | NCT00774904 | Completed | Adiponectin and Insulin Resistance in Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Older Adult) | NCT00774904 | ADPN | April 2007 | October 2007 | November 2007 | October 17, 2008 | October 20, 2008 |
|
|||
45 | NCT02327754 | Completed | Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
60 | All | 20 Years to 75 Years (Adult, Older Adult) | NCT02327754 | FY1004 | UPWARD | December 2016 | December 2016 | December 30, 2014 | April 12, 2017 |
|
|||
46 | NCT00340678 | Completed Has Results |
Renoprotection in Early Diabetic Nephropathy in Pima Indians |
|
|
Interventional |
Phase 3 |
|
NIH |
|
|
170 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00340678 | 999995037 OH95-DK-N037 |
August 1995 | May 2012 | March 2014 | June 21, 2006 | July 24, 2014 | November 19, 2013 |
|
||
47 | NCT01968668 | Completed | Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
96 | All | 18 Years and older (Adult, Older Adult) | NCT01968668 | 16816 | October 2013 | October 2014 | November 2014 | October 24, 2013 | January 9, 2015 |
|
|||
48 | NCT00353600 | Completed | Delaying the Progression of Diabetic Nephropathy in Pima Indians |
|
Observational |
|
NIH | 25 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00353600 | 999994034 OH94-DK-N034 |
August 19, 1994 | August 16, 2011 | July 18, 2006 | July 2, 2017 |
|
||||||||
49 | NCT02676401 | Completed | An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
241 | All | 20 Years to 75 Years (Adult, Older Adult) | NCT02676401 | MT-3995-J06 | February 2016 | August 2017 | February 8, 2016 | September 18, 2017 |
|
||||
50 | NCT03284996 | Not yet recruiting | Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus. |
|
|
Observational |
|
Other |
|
|
80 | All | 25 Years to 65 Years (Adult, Older Adult) | NCT03284996 | DUDN | October 1, 2017 | April 30, 2019 | September 1, 2019 | September 15, 2017 | September 15, 2017 | |||||
51 | NCT00664027 | Completed | Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
80 | All | 18 Years and older (Adult, Older Adult) | NCT00664027 | RTA 402-C-0801 | April 2008 | May 2009 | April 22, 2008 | December 3, 2012 |
|
||||
52 | NCT03165240 | Recruiting | This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 4 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
105 | All | 18 Years and older (Adult, Older Adult) | NCT03165240 | 1378-0008 2017-000563-32 |
October 5, 2017 | December 30, 2019 | December 30, 2019 | May 24, 2017 | February 5, 2019 |
|
|||
53 | NCT00136188 | Completed | Nitric Oxide (NO) Activity and Diabetic Nephropathy |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
100 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00136188 | SFB 423 TP B5 | August 2009 | December 2011 | December 2011 | August 26, 2005 | June 19, 2012 |
|
|||
54 | NCT00498537 | Completed | Spironolactone for Reducing Proteinuria in Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
U.S. Fed |
|
|
30 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT00498537 | 0024 | January 2003 | December 2005 | June 2006 | July 10, 2007 | October 17, 2008 |
|
|||
55 | NCT00363987 | Completed | Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
179 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00363987 | BFP503 | May 2006 | December 2008 | June 2009 | August 15, 2006 | September 2, 2010 |
|
|||
56 | NCT01300273 | Unknown † | Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
60 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01300273 | KETO-011-IP4 | February 2011 | May 2012 | July 2012 | February 21, 2011 | September 8, 2011 |
|
|||
57 | NCT00153088 | Completed | INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
527 | All | 30 Years to 74 Years (Adult, Older Adult) | NCT00153088 | 502.413 | January 2003 | November 2005 | November 2005 | September 12, 2005 | November 1, 2013 |
|
|||
58 | NCT02689778 | Active, not recruiting | Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Other / Industry |
|
|
62 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02689778 | 1497 | March 2016 | March 2019 | December 2019 | February 24, 2016 | May 7, 2018 |
|
|||
59 | NCT02384902 | Completed | Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
90 | All | 30 Years to 75 Years (Adult, Older Adult) | NCT02384902 | low GI nephropathy | May 2014 | July 2014 | July 2014 | March 10, 2015 | March 10, 2015 |
|
|||
60 | NCT02986984 | Recruiting | Transformative Research in Diabetic Nephropathy |
|
|
Observational |
|
Other / Industry |
|
|
300 | All | 18 Years to 100 Years (Adult, Older Adult) | NCT02986984 | 824503 | TRIDENT | December 2016 | November 2019 | July 2020 | December 8, 2016 | November 14, 2018 |
|
|||
61 | NCT01094769 | Unknown † | Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
48 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01094769 | 2010/10 58667 |
April 2011 | January 2015 | April 2015 | March 29, 2010 | December 18, 2013 |
|
|||
62 | NCT00663949 | Completed | Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
70 | All | 30 Years to 70 Years (Adult, Older Adult) | NCT00663949 | 3079 | February 2006 | December 2007 | January 2008 | April 22, 2008 | April 22, 2008 |
|
|||
63 | NCT01874431 | Completed | Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
823 | All | 18 Years and older (Adult, Older Adult) | NCT01874431 | 16243 2012-004179-38 |
ARTS-DN | June 2013 | July 2014 | August 2014 | June 11, 2013 | August 13, 2015 |
|
||
64 | NCT01493050 | Completed | The Effects of Sevelamer Carbonate on Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
117 | All | 18 Years and older (Adult, Older Adult) | NCT01493050 | GCO 11-0973 | February 2012 | December 2013 | December 2013 | December 15, 2011 | April 9, 2014 |
|
|||
65 | NCT00240019 | Completed | Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
30 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00240019 | R01-063011 R01DK063011 |
December 2003 | April 2006 | October 17, 2005 | October 17, 2006 |
|
||||
66 | NCT00120328 | Terminated | To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
2364 | All | 21 Years to 80 Years (Adult, Older Adult) | NCT00120328 | SPP301CRD15 2005-000604-14 |
July 2005 | February 2007 | July 15, 2005 | October 5, 2007 |
|
||||
67 | NCT02194790 | Completed | Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
238 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02194790 | CICC program | December 2012 | December 2013 | December 2013 | July 18, 2014 | July 18, 2014 |
|
|||
68 | NCT02164279 | Completed | Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
140 | All | 6 Years to 30 Years (Child, Adult) | NCT02164279 | 12 356 03 2012-A01097-36 |
peeDIAB2 | June 2013 | December 2015 | December 2015 | June 16, 2014 | January 12, 2016 |
|
||
69 | NCT01726816 | Completed | Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
126 | All | 20 Years to 80 Years (Adult, Older Adult) | NCT01726816 | 009-KOA-1201i | October 2012 | April 2014 | September 2014 | November 15, 2012 | May 3, 2017 |
|
|||
70 | NCT03445247 | Recruiting | Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03445247 | 104-7771A | July 1, 2017 | June 30, 2019 | June 30, 2020 | February 26, 2018 | February 26, 2018 |
|
|||
71 | NCT01673204 | Unknown † | Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
276 | All | 19 Years to 80 Years (Adult, Older Adult) | NCT01673204 | SNUH-TNFR | October 2012 | April 2014 | August 27, 2012 | February 13, 2014 |
|
||||
72 | NCT03690180 | Completed | Hypomagnesemia and Diabetic Nephropathy |
|
|
Observational |
|
Other |
|
|
100 | All | 20 Years and older (Adult, Older Adult) | NCT03690180 | VCG5 | January 1, 2018 | January 30, 2018 | February 28, 2018 | October 1, 2018 | October 1, 2018 |
|
||||
73 | NCT00448526 | Terminated | Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
All | 20 Years to 65 Years (Adult, Older Adult) | NCT00448526 | H8-H-077 | LPD | December 1997 | August 2006 | March 19, 2007 | March 19, 2007 | |||||
74 | NCT01843387 | Completed | Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
30 | All | 50 Years to 85 Years (Adult, Older Adult) | NCT01843387 | MSB-DN001 | July 2013 | September 2014 | September 2015 | April 30, 2013 | October 14, 2016 |
|
|||
75 | NCT00419835 | Completed | Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
80 | All | 30 Years and older (Adult, Older Adult) | NCT00419835 | ST01 | May 2005 | September 2007 | September 2007 | January 9, 2007 | August 4, 2011 |
|
|||
76 | NCT03681704 | Not yet recruiting | the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
144 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03681704 | 17401970500-a | October 2018 | September 2021 | September 2021 | September 24, 2018 | September 24, 2018 |
|
|||
77 | NCT03681249 | Recruiting | the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
144 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03681249 | 17401970500-b | November 2, 2018 | September 2021 | September 2021 | September 24, 2018 | November 9, 2018 |
|
|||
78 | NCT03535935 | Recruiting | Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
118 | All | 35 Years to 80 Years (Adult, Older Adult) | NCT03535935 | RE-02 | READY | July 1, 2018 | June 30, 2022 | December 31, 2022 | May 24, 2018 | October 11, 2018 |
|
||
79 | NCT03212755 | Not yet recruiting | Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
75 | All | 30 Years to 70 Years (Adult, Older Adult) | NCT03212755 | PRUD | August 2017 | June 2019 | December 2019 | July 11, 2017 | July 11, 2017 | ||||
80 | NCT01521910 | Completed | Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
82 | All | 18 Years to 60 Years (Adult) | NCT01521910 | Low Protein Diet | LPD | April 1995 | June 2000 | June 2000 | January 31, 2012 | January 31, 2012 |
|
||
81 | NCT00421733 | Completed Has Results |
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
281 | All | 20 Years and older (Adult, Older Adult) | NCT00421733 | M05-741 2006-001363-31 |
VITAL | December 2006 | June 2009 | June 2009 | January 12, 2007 | January 20, 2012 | September 14, 2010 |
|
|
82 | NCT03625648 | Not yet recruiting | Pentoxifylline in Diabetic Kidney Disease |
|
|
Interventional |
Phase 4 |
|
U.S. Fed |
|
|
2510 | All | 18 Years and older (Adult, Older Adult) | NCT03625648 | 2008 | PTXRx | June 3, 2019 | January 3, 2028 | July 8, 2030 | August 10, 2018 | January 23, 2019 |
|
||
83 | NCT00312780 | Completed | Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
125 | All | 18 Years and older (Adult, Older Adult) | NCT00312780 | XL784-201 | March 2006 | October 2007 | December 2007 | April 11, 2006 | February 23, 2010 |
|
|||
84 | NCT02156843 | Terminated | Pyridorin in Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
328 | All | 18 Years and older (Adult, Older Adult) | NCT02156843 | PYR-311 2014-001641-24 CSG-17 PYR-311 (PIONEER) |
PIONEER | June 2014 | December 2017 | March 2018 | June 5, 2014 | March 9, 2016 |
|
||
85 | NCT01588795 | Completed | Renal Denervation in Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
25 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01588795 | P110122 | DERENEDIAB | April 2012 | January 2016 | January 2016 | May 1, 2012 | June 1, 2016 |
|
||
86 | NCT01566006 | Unknown † | Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
80 | All | 30 Years to 80 Years (Adult, Older Adult) | NCT01566006 | nazh8827ctil | Myridian | April 2012 | June 2013 | August 2013 | March 29, 2012 | March 29, 2012 |
|
||
87 | NCT02501772 | Unknown † | The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
60 | All | 20 Years to 80 Years (Adult, Older Adult) | NCT02501772 | 14MMHIS139 | September 2014 | August 2015 | September 2015 | July 17, 2015 | July 28, 2015 |
|
|||
88 | NCT02251067 | Completed | Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
165 | All | 21 Years to 80 Years (Adult, Older Adult) | NCT02251067 | VPI-CLIN-201-AD | September 2014 | March 2017 | March 2017 | September 26, 2014 | March 28, 2017 |
|
|||
89 | NCT00130208 | Completed Has Results |
Effect of Sulodexide in Early Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
1056 | All | 18 Years and older (Adult, Older Adult) | NCT00130208 | KRX-101-301 | August 2005 | January 2008 | February 2008 | August 15, 2005 | March 23, 2018 | March 23, 2018 |
|
||
90 | NCT03820635 | Not yet recruiting New |
Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy |
|
|
Observational |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03820635 | MVasCDN | March 1, 2019 | July 1, 2020 | September 1, 2020 | January 29, 2019 | January 29, 2019 |
|
||||
91 | NCT01923597 | Completed | Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
50 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT01923597 | Fapesp-2013 | November 2013 | March 2015 | March 2015 | August 15, 2013 | August 4, 2016 |
|
|||
92 | NCT00518362 | Completed | To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
67 | All | 35 Years to 65 Years (Adult, Older Adult) | NCT00518362 | NJCT-0701 | July 2007 | September 2009 | March 2010 | August 20, 2007 | May 27, 2010 |
|
|||
93 | NCT00067678 | Completed | Soy Protein in Early Diabetic Nephropathy |
|
|
Interventional |
Phase 1 Phase 2 |
|
NIH |
|
All | 18 Years to 40 Years (Adult) | NCT00067678 | R21AT000323-01 | July 2001 | June 2003 | August 27, 2003 | August 18, 2006 |
|
||||||
94 | NCT03622762 | Recruiting | Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
30 | All | 40 Years to 65 Years (Adult, Older Adult) | NCT03622762 | CUCS-INTEC-MV-ERVE-06 | July 15, 2018 | December 15, 2018 | June 20, 2019 | August 9, 2018 | August 21, 2018 |
|
|||
95 | NCT01967901 | Completed | Impact of Multidisciplinary Self-care Management of Diabetic Nephropathy on Quality of Life, Self-care Behavior, Glycemic Control, and Renal Function. |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
36 | All | 18 Years to 95 Years (Adult, Older Adult) | NCT01967901 | 37319/S-RAD13-07 | March 2014 | February 2016 | February 2016 | October 23, 2013 | May 18, 2016 |
|
|||
96 | NCT03165227 | Recruiting | This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
75 | All | 18 Years and older (Adult, Older Adult) | NCT03165227 | 1366-0004 2014-004541-27 |
October 17, 2017 | November 15, 2019 | November 15, 2019 | May 24, 2017 | February 12, 2019 |
|
|||
97 | NCT00914524 | Completed | Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
49 | All | 20 Years to 70 Years (Adult, Older Adult) | NCT00914524 | CS0866-C-J201 | January 2005 | April 2006 | October 2006 | June 5, 2009 | September 29, 2010 |
|
|||
98 | NCT02040441 | Completed | Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
1777 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02040441 | 2012-000452-34 | PRIORITY | March 2014 | November 2018 | November 2018 | January 20, 2014 | December 21, 2018 |
|
||
99 | NCT01331317 | Completed | Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
48 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01331317 | 2009-011255-44 | April 2010 | April 2012 | April 2012 | April 8, 2011 | April 13, 2012 |
|
|||
100 | NCT02065791 | Completed | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Industry / Other |
|
|
4402 | All | 30 Years and older (Adult, Older Adult) | NCT02065791 | CR103517 2013-004494-28 28431754DNE3001 |
CREDENCE | February 17, 2014 | October 30, 2018 | October 30, 2018 | February 19, 2014 | January 25, 2019 |
|
† Study has passed its completion date and status has not been verified in more than two years.